- Home
- NSTS vs BEAT Comparison
NSTS vs BEAT Comparison
Compare NSTS & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- BEAT
- Stock Information
- Founded
- NSTS 1921
- BEAT 2015
- Country
- NSTS United States
- BEAT United States
- Employees
- NSTS N/A
- BEAT N/A
- Industry
- NSTS Savings Institutions
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- NSTS Finance
- BEAT Technology
- Exchange
- NSTS Nasdaq
- BEAT Nasdaq
- Market Cap
- NSTS 63.1M
- BEAT 74.1M
- IPO Year
- NSTS N/A
- BEAT 2021
- Fundamental
- Price
- NSTS $12.00
- BEAT $2.14
- Analyst Decision
- NSTS
- BEAT Buy
- Analyst Count
- NSTS 0
- BEAT 1
- Target Price
- NSTS N/A
- BEAT $8.00
- AVG Volume (30 Days)
- NSTS 4.2K
- BEAT 117.1K
- Earning Date
- NSTS 11-13-2024
- BEAT 11-07-2024
- Dividend Yield
- NSTS N/A
- BEAT N/A
- EPS Growth
- NSTS N/A
- BEAT N/A
- EPS
- NSTS N/A
- BEAT N/A
- Revenue
- NSTS $6,117,000.00
- BEAT N/A
- Revenue This Year
- NSTS N/A
- BEAT N/A
- Revenue Next Year
- NSTS N/A
- BEAT N/A
- P/E Ratio
- NSTS N/A
- BEAT N/A
- Revenue Growth
- NSTS N/A
- BEAT N/A
- 52 Week Low
- NSTS $9.35
- BEAT $1.35
- 52 Week High
- NSTS $12.05
- BEAT $3.48
- Technical
- Relative Strength Index (RSI)
- NSTS 61.77
- BEAT 39.59
- Support Level
- NSTS $11.25
- BEAT $2.00
- Resistance Level
- NSTS $12.05
- BEAT $2.30
- Average True Range (ATR)
- NSTS 0.17
- BEAT 0.16
- MACD
- NSTS 0.00
- BEAT -0.00
- Stochastic Oscillator
- NSTS 93.79
- BEAT 35.00
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in our market area of Lake County, Illinois and adjacent communities.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.